Clad in medical scrubs, every A-listers favorite face guru, Nurse Jamie, offers a glimpse of the woman behind the white coat. Born Jamie Sue Sherrill in Indiana - she and Catt bond over this! - Nurse Jamie talks about competing in beauty pageants, landing a flight attendant job in college and having a life-long dedication to beauty. She also shares a surprising story about how she ended up in LA (which, spoiler alert, involves a date with a stranger and a whole lot of Klondike bars).

And of course, Nurse Jamie shares some of her favorite skincare tips and tricks, answers some of your questions about injectables and her line of beauty tools, and discusses why she uses Xeomin in some of her clients. 

You won't want to miss one of Catt's shares in this episode either -- it's a lip injection horror story from her days on TV! She also talks about how watching her mother undergo cosmetic procedures proved to her that beauty and feminism are not mutually exclusive.

*This episode was produced in partnership with Xeomin. You can follow @XeominAesthetic and check out xeominaesthetic.com to find a provider and see if Xeomin may be right for you.

Studies have not been performed to determine whether the presence or absence of accessory proteins has a long-term effect on safety or efficacy. For full Prescribing Information including Boxed Warning and Medication Guide, see http://bit.ly/2Ang59B. Xeomin® is an FDA-approved treatment used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults. Ask your doctor to tell you all about Xeomin. The effects of Xeomin may spread hours to weeks after injection causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. Side effects may include allergic reactions or injection-site pain, eyelid drooping, and swelling. Xeomin is available by prescription only.

See omnystudio.com/listener for privacy information.